Tetrapeptide-21

Tetrapeptide-21 (Lys-Asp-Val-Tyr) is a synthetic collagen-stimulating tetrapeptide designed to activate the TGF-β (transforming growth factor beta) signaling pathway in dermal fibroblasts. It represents the smaller, unmodified tetrapeptide approach to collagen stimulation, in contrast to fatty acid-conjugated peptides like palmitoyl pentapeptide-4 (Matrixyl) or palmitoyl tripeptide-1.

**Mechanism of action:** Tetrapeptide-21 binds to TGF-β receptor complexes or upstream co-receptors on fibroblasts, activating the SMAD2/3 intracellular signaling cascade that drives procollagen gene transcription. Key effects:

1. **Procollagen type I alpha 1 (COL1A1)**: Upregulation of gene expression for the major structural collagen of dermis 2. **Procollagen type III (COL3A1)**: Upregulation of the "reticulin" collagen predominant in younger skin 3. **TIMP-1 (Tissue Inhibitor of Metalloproteinase-1)**: Increased expression inhibits MMP collagenases 4. **MMP-1 suppression**: Reduces collagenase activity in the dermal microenvironment

The combination of stimulating new collagen synthesis AND reducing collagen breakdown produces a net increase in dermal collagen content.

**Positioning within cosmetic peptide landscape:** Tetrapeptide-21 occupies a position similar to palmitoyl tripeptide-1 (Pal-GHK) in that both stimulate collagen via related TGF-β pathways. The key difference is that Pal-GHK has an N-terminal palmitoyl modification that enhances lipophilicity and skin penetration through the stratum corneum, while Tetrapeptide-21 is unmodified and hydrophilic — requiring appropriate delivery systems (nanoparticles, liposomes, or high formulation concentration) for optimal penetration.

When combined with Matrixyl (palmitoyl pentapeptide-4), which acts through distinct TGF-β and decorin-related pathways, Tetrapeptide-21 may provide complementary or additive collagen stimulation. Multi-peptide anti-aging serums increasingly incorporate 3-5 different peptide actives targeting different pathways simultaneously.